The first new crown prevention antibody to the ground Boao Le City for immune vulnerability people

Economic Observation Network reporter Qu Yixian on July 9th, the world's only neutralized antibody drug group EVUSHELD (Chinese product name: Eunchang), which can be used for pre -exposure prevention pre -exposed prevention, in the world. City) Complete the first injection.

Because Evusheld has not yet been listed in China, the antibody drug can be used first in Lecheng according to the relevant policies of the "National Nine Articles" franchise. On July 9, many people who needed to complete injections at Ruijin Hainan Hospital and Boao Super Hospital. The drug is one -time injection, the dose is 300mg+300mg, and the total cost is 13,300 yuan.

The Economic Observation Network learned that dozens of people have made an appointment in the two hospitals, mainly for the recent planning population.

EVUSHELD is composed of two types of full -person long -effect monoclonal antibodies tixagevimab and Cilgavimab antibody composition, which can simulate the human body's natural antibody defense mechanism. The combination of different sites above reducing the ability of virus to enter and infected healthy cells, and helps to remove the infected cells.

The latest clinical "living" virus data of the University of Washington Medical College shows that Evusheld has strong neutralization of the main epidemic plants currently including Omitron.

Qu Jieming, Secretary of the Party Committee of Ruijin Hospital and Department of Respiratory Medicine, Affiliated to the School of Medicine, Shanghai Jiaotong University, told the Economic Observation Network that vaccines are the most effective way from the perspective of preventing infectious diseases, but there are also some people who are not suitable for vaccination for various reasons. For example, there are contraindications, or inadequate immune response, vaccination but not good immune effects. This group of people is immune and fragile. And immune fragile people need more protection, because these people are prone to infection and are easily developed into severe illnesses after infection.

Qu Jieming said that in the future, the epidemic has entered the stage of normalization prevention and control. If key groups, fragile groups, crowds are prone to infection, and are easily developed into severe critical and severe people after infection, they can really be protected in the first time, and they can truly achieve normalization prevention prevention. Control, there will be no crowding of medical resources.

From the perspective of protecting immune fragile people, EVUSHELD, as a long -effect neutralized antibody against the new coronal virus, is preferentially applied to the prevention of new coronal virus infection of the new coronal virus infection of people with damaged immune function or low immunity, including malignant hematological tumors that are being accepted by chemotherapy or other Patients with tumor patients, patients who take medication after transplantation, patients with dialysis, and patients with immunosuppressive drugs and diseases such as immunosuppressive drugs and diseases such as rheumatoid arthritis.

In addition, EVUSHELD can provide "instant" and "lasting" protection for people who have poor effects and need additional protection except vaccine.

Data show that about 2%of people around the world still face the risk of new crown virus due to insufficient immune response to the new crown vaccine. In addition, according to China's latest "Ninth Edition New Coronatte Pneumonic Pneumonia Prevention Plan", the working policy of the low immunity should be accurately positioned, including the elderly, the patients with basic diseases, the tumor patients who are undergoing chemotherapy, and the organ transplantation of the organ transplantation. Patients, dialysis patients, and patients who are using immunosuppressive drugs. EVUSHELD's landscape Music City can be used for new coronary virus (age ≥12 years of age and weight ≥40kg) for adults and adolescents.

- END -